Clinical Trial Update: A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects [Phase 1]

View source ↗

Summary

This is a first-in-human Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of single and repeat escalating doses of GSK2878175 in healthy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• GSK2878175

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis C, Chronic | Phase 1 | Status: COMPLETED